Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank33
3Y CAGR-50.9%
5Y CAGR-61.0%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

3Y CAGR
-50.9%/yr
Annual compound
5Y CAGR
-61.0%/yr
Recent acceleration
Percentile
P33
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
20251.76%
2024121.60%
2023-6.79%
202214.90%
2021104.41%
2020194.37%
20190.00%